Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Regeneron Pharmaceuticals Inc. buy geldnutzer

Regeneron Pharmaceuticals Inc.
Start price
€442.80
23.11.20 / 80%
Target price
€555.00
23.11.21
Performance (%)
29.97%
End price
€575.50
24.11.21
Summary
This prediction ended on 24.11.21 with a price of €575.50. The BUY prediction by geldnutzer finished with a performance of 29.97%. geldnutzer has 80% into this prediction

Regeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.

Performance without dividends (%)
Name 1w 1m 1y 3y
Regeneron Pharmaceuticals Inc. -2.076% -2.076% 13.999% 100.119%
iShares Core DAX® -1.670% -1.001% 10.864% 12.563%
iShares Nasdaq 100 -4.184% -1.145% 37.458% 41.078%
iShares Nikkei 225® -4.967% -5.783% 18.828% 0.655%
iShares S&P 500 -2.834% -0.572% 25.875% 39.960%

According to geldnutzer what are the pros and cons of Regeneron Pharmaceuticals Inc. for the foreseeable future?

Pros
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Small challenges to pay loans and raise capital
Very valuable balance sheet
Top Rating
Very positive Cash Flow expected
Capable Management
Leading role in innovation
Strong uniques
Very differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Small Risks for its business
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Small cyclical dependencies
Known brand
Cons

Comments by geldnutzer for this prediction

In the thread Regeneron Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 29.97%
Target price 456.000
Change
Ends at 23.11.21

Buy mit Kursziel 456,0

geldnutzer 
0
Report Share
23.11.20
Prediction Buy
Perf. (%) 29.97%
Target price 406.000
Change
Ends at 23.11.21

Kursziel geändert auf 406,0

geldnutzer 
0
Report Share
10.12.20
Prediction Buy
Perf. (%) 29.97%
Target price 450.000
Change
Ends at 23.11.21

Kursziel geändert auf 450,0

geldnutzer 
0
Report Share
14.12.20
Prediction Buy
Perf. (%) 29.97%
Target price 420.000
Change
Ends at 23.11.21

Kursziel geändert auf 420,0

geldnutzer 
0
Report Share
22.12.20
Prediction Buy
Perf. (%) 29.97%
Target price 400.000
Change
Ends at 23.11.21

Kursziel geändert auf 400,0

geldnutzer 
0
Report Share
08.01.21
Prediction Buy
Perf. (%) 29.97%
Target price 420.000
Change
Ends at 23.11.21

Kursziel geändert auf 420,0

geldnutzer 
0
Report Share
08.01.21
Prediction Buy
Perf. (%) 29.97%
Target price 585.000
Change
Ends at 23.11.21

Kursziel geändert auf 585,0

geldnutzer 
0
Report Share
10.01.21
Prediction Buy
Perf. (%) 29.97%
Target price 485.000
Change
Ends at 23.11.21

Kursziel geändert auf 485,0

geldnutzer 
0
Report Share
12.01.21
Prediction Buy
Perf. (%) 29.97%
Target price 405.000
Change
Ends at 23.11.21

Kursziel geändert auf 405,0

geldnutzer 
0
Report Share
20.02.21
Prediction Buy
Perf. (%) 29.97%
Target price 425.000
Change
Ends at 23.11.21

Kursziel geändert auf 425,0

geldnutzer 
0
Report Share
19.04.21
Prediction Buy
Perf. (%) 29.97%
Target price 525.000
Change
Ends at 23.11.21

Kursziel geändert auf 525,0

geldnutzer 
0
Report Share
10.07.21
Prediction Buy
Perf. (%) 29.97%
Target price 565.000
Change
Ends at 23.11.21

Kursziel geändert auf 565,0

geldnutzer 
0
Report Share
01.11.21
Prediction Buy
Perf. (%) 29.97%
Target price 575.000
Change
Ends at 23.11.21

Kursziel geändert auf 575,0

geldnutzer 
0
Report Share
05.11.21
Prediction Buy
Perf. (%) 29.97%
Target price 555.000
Change
Ends at 23.11.21

Kursziel geändert auf 555,0

geldnutzer 
0
Report Share
11.11.21
In the thread Trading Regeneron Pharmaceuticals Inc.
Prediction Sell
Perf. (%) 29.97%
Target price 555.000
Change
Ends at 23.11.21

Die von geldnutzer gewählte maximale Laufzeit wurde überschritten

geldnutzer 
0
Report Share
24.11.21

Stopped prediction by geldnutzer for Regeneron Pharmaceuticals Inc.

sell
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€437.60
19.11.20
€426.00
19.11.21
1.19%
23.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
19.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€453.60
01.09.17
€526.00
04.11.21
-3.53%
19.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
15.08.19 50%